skip to Main Content

LED Medical Diagnostics Announces Warrant Extension

  • October 09, 2015
  • News Releases

Vancouver, British Columbia, October 8, 2015 – LED Medical Diagnostics Inc. (“LED” or the “Company”) (TSX-V: LMD) announced today that it is proposing a 12 month extension to the term of outstanding share purchase warrants (the “Warrants”) exercisable at a price of US$0.50 per common share for 14,661,989 common shares of LED, which were originally issued pursuant to a private placement that completed on October 24, 2013.  All of the Warrants were originally exercisable for 24 months from the date of issuance.

The extension of the Warrants is subject to TSX Venture Exchange acceptance. All other terms of the Warrants will remain unchanged.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the TSX-V under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”.  For more information, call 884.952.7327 or visit